Literature DB >> 18991368

A novel method to label preformed liposomes with 64Cu for positron emission tomography (PET) imaging.

Jai Woong Seo1, Hua Zhang, David L Kukis, Claude F Meares, Katherine W Ferrara.   

Abstract

Radiolabeling of liposomes with 64Cu (t(1/2)=12.7 h) is attractive for molecular imaging and monitoring drug delivery. A simple chelation procedure, performed at a low temperature and under mild conditions, is required to radiolabel preloaded liposomes without lipid hydrolysis or the release of the encapsulated contents. Here, we report a 64Cu postlabeling method for liposomes. A 64Cu-specific chelator, 6-[p-(bromoacetamido)benzyl]-1,4,8,11-tetraazacyclotetradecane-N,N',N'',N'''-tetraacetic acid (BAT), was conjugated with an artificial lipid to form a BAT-PEG-lipid. After incorporation of 0.5% (mol/mol) BAT-PEG-lipid during liposome formulation, liposomes were successfully labeled with 64Cu in 0.1 M NH4OAc pH 5 buffer at 35 degrees C for 30-40 min with an incorporation yield as high as 95%. After 48 h of incubation of 64Cu-liposomes in 50/50 serum/PBS solution, more than 88% of the 64Cu label was still associated with liposomes. After injection of liposomal 64Cu in a mouse model, 44+/-6.9, 21+/-2.7, 15+/-2.5, and 7.4+/-1.1 (n=4) % of the injected dose per cubic centimeter remained within the blood pool at 30 min, 18, 28, and 48 h, respectively. The biodistribution at 48 h after injection verified that 7.0+/-0.47 (n=4) and 1.4+/-0.58 (n=3) % of the injected dose per gram of liposomal 64Cu and free 64Cu remained in the blood pool, respectively. Our results suggest that this fast and easy 64Cu labeling of liposomes could be exploited in tracking liposomes in vivo for medical imaging and targeted delivery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18991368      PMCID: PMC2756669          DOI: 10.1021/bc8002937

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  34 in total

1.  A simple method for producing a technetium-99m-labeled liposome which is stable in vivo.

Authors:  W T Phillips; A S Rudolph; B Goins; J H Timmons; R Klipper; R Blumhardt
Journal:  Int J Rad Appl Instrum B       Date:  1992-07

2.  Simplified method for conjugating macrocyclic bifunctional chelating agents to antibodies via 2-iminothiolane.

Authors:  M J McCall; H Diril; C F Meares
Journal:  Bioconjug Chem       Date:  1990 May-Jun       Impact factor: 4.774

3.  Novel amphiphilic probes for [18F]-radiolabeling preformed liposomes and determination of liposomal trafficking by positron emission tomography.

Authors:  Takeo Urakami; Shuji Akai; Yurie Katayama; Norihiro Harada; Hideo Tsukada; Naoto Oku
Journal:  J Med Chem       Date:  2007-12-01       Impact factor: 7.446

4.  Increased delivery of gallium-67 to tumors using serum-stable liposomes.

Authors:  I Ogihara-Umeda; S Kojima
Journal:  J Nucl Med       Date:  1988-04       Impact factor: 10.057

5.  Metabolism of radiocopper (Cu64) in the rat.

Authors:  C A Owen
Journal:  Am J Physiol       Date:  1965-11

6.  Improved synthesis of 6-[p-(bromoacetamido)benzyl]-1,4,8,11-tetraazacyclotetradecane- N,N',N",N"-tetraacetic acid and development of a thin-layer assay for thiol-reactive bifunctional chelating agents.

Authors:  J K Moran; D P Greiner; C F Meares
Journal:  Bioconjug Chem       Date:  1995 May-Jun       Impact factor: 4.774

7.  Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugates.

Authors:  D L Kukis; G L DeNardo; S J DeNardo; G R Mirick; L A Miers; D P Greiner; C F Meares
Journal:  Cancer Res       Date:  1995-02-15       Impact factor: 12.701

8.  A comparative study of copper-67 radiolabeling and kinetic stabilities of antibody-macrocycle chelate conjugates.

Authors:  D L Kukis; H Diril; D P Greiner; S J DeNardo; G L DeNardo; Q A Salako; C F Meares
Journal:  Cancer       Date:  1994-02-01       Impact factor: 6.860

9.  Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.

Authors:  A Gabizon; D Papahadjopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

10.  Attachment of 99mTc to lipid vesicles containing the lipophilic chelate dipalmitoylphosphatidylethanolamine-DTTA.

Authors:  Q F Ahkong; C Tilcock
Journal:  Int J Rad Appl Instrum B       Date:  1992-11
View more
  47 in total

1.  Copper-doxorubicin as a nanoparticle cargo retains efficacy with minimal toxicity.

Authors:  Azadeh Kheirolomoom; Lisa M Mahakian; Chun-Yen Lai; Heather A Lindfors; Jai Woong Seo; Eric E Paoli; Katherine D Watson; Eric M Haynam; Elizabeth S Ingham; Li Xing; R Holland Cheng; Alexander D Borowsky; Robert D Cardiff; Katherine W Ferrara
Journal:  Mol Pharm       Date:  2010-12-06       Impact factor: 4.939

2.  Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions.

Authors:  Natalya Rapoport; Kweon-Ho Nam; Roohi Gupta; Zhongao Gao; Praveena Mohan; Allison Payne; Nick Todd; Xin Liu; Taeho Kim; Jill Shea; Courtney Scaife; Dennis L Parker; Eun-Kee Jeong; Anne M Kennedy
Journal:  J Control Release       Date:  2011-01-26       Impact factor: 9.776

Review 3.  Leveraging the power of ultrasound for therapeutic design and optimization.

Authors:  Charles F Caskey; Xiaowen Hu; Katherine W Ferrara
Journal:  J Control Release       Date:  2011-07-30       Impact factor: 9.776

4.  Ultrasound increases nanoparticle delivery by reducing intratumoral pressure and increasing transport in epithelial and epithelial-mesenchymal transition tumors.

Authors:  Katherine D Watson; Chun-Yen Lai; Shengping Qin; Dustin E Kruse; Yueh-Chen Lin; Jai Woong Seo; Robert D Cardiff; Lisa M Mahakian; Julie Beegle; Elizabeth S Ingham; Fitz-Roy Curry; Rolf K Reed; Katherine W Ferrara
Journal:  Cancer Res       Date:  2012-01-26       Impact factor: 12.701

5.  Membrane Loaded Copper Oleate PEGylated Liposome Combined with Disulfiram for Improving Synergistic Antitumor Effect In Vivo.

Authors:  Lingli Zhou; Liu Yang; Chulei Yang; Yi Liu; Qiuyue Chen; Wenli Pan; Qing Cai; Lifeng Luo; Lu Liu; Shan Jiang; Haibing He; Yu Zhang; Tian Yin; Xing Tang
Journal:  Pharm Res       Date:  2018-05-23       Impact factor: 4.200

6.  The pharmacokinetics of Zr-89 labeled liposomes over extended periods in a murine tumor model.

Authors:  Jai Woong Seo; Lisa M Mahakian; Sarah Tam; Shengping Qin; Elizabeth S Ingham; Claude F Meares; Katherine W Ferrara
Journal:  Nucl Med Biol       Date:  2014-09-28       Impact factor: 2.408

7.  An optical and microPET assessment of thermally-sensitive liposome biodistribution in the Met-1 tumor model: Importance of formulation.

Authors:  E E Paoli; D E Kruse; J W Seo; H Zhang; A Kheirolomoom; K D Watson; P Chiu; H Stahlberg; K W Ferrara
Journal:  J Control Release       Date:  2009-12-16       Impact factor: 9.776

Review 8.  Self-assembled lipid nanomedicines for siRNA tumor targeting.

Authors:  Yu-Cheng Tseng; Leaf Huang
Journal:  J Biomed Nanotechnol       Date:  2009-08       Impact factor: 4.099

Review 9.  Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy.

Authors:  Gann Ting; Chih-Hsien Chang; Hsin-Ell Wang; Te-Wei Lee
Journal:  J Biomed Biotechnol       Date:  2010-08-03

10.  An imaging-driven model for liposomal stability and circulation.

Authors:  Shengping Qin; Jai Woong Seo; Hua Zhang; Jinyi Qi; Fitz-Roy E Curry; Katherine W Ferrara
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.